Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2395012 Title: Molécules d'ARNsi modifiées et leurs utilisations

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
111698650
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
2395012
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
02/11/2006
Grant date:
18/04/2018
EP publication date:
14/12/2011
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
18/04/2018
EP B1 publication date:
18/04/2018
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/11/2018
Expiration date (if granted and all annual fees paid):
02/11/2026

Applicant

Name:
Protiva Biotherapeutics Inc.
Legal Form:
From:
18/04/2018
Address:
100-8900 Glenlyon Parkway, Burnaby, British Columbia V5J 5J8, Canada (CA)
To:

Inventor

1

Name:
Judge, Adam
Legal Form:
Address:
Vancouver, British Columbia V6J 2C6, Canada (CA)

2

Name:
MacLachan, Ian
Legal Form:
Address:
Mission, British Columbia V4S 1E5, Canada (CA)

Priority

1

Priority patent number:
732964 P
Priority date:
02/11/2005
Priority country:
United States (US)

2

Priority patent number:
817933 P
Priority date:
30/06/2006
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 48/00; A61K 31/713; C12N 15/113; A61K 9/127; C12N 15/11;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2018/10
Publication date:
15/06/2018
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2019/21
Publication date:
19/08/2019
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

1

Issue number:
201816
Publication date:
18/04/2018
Description:
Grant (B1)

2

Issue number:
201823
Publication date:
06/06/2018
Description:
Document reprinted after correction (B8, B9)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type